THE CRISPR FORUM 2017
This unique meeting was held in Dublin on 17-18 October and brought together leaders in the field together with a wide academic and commercial audience, to explore the new horizons in drug development and therapeutics brought by advancements in CRISPR technology.
The discovery of the RNA programmable nucleases Cas9 and Cpf1 has revolutionized a researcher's ability to interrogate and understand genes. The impact of CRISPR genome editing technology has been universal and unescapable, bringing drug discovery to an era of whole genome knockout screens and development of translational in vitro and in vivo models of disease, as well as moving into the clinic, progressing towards transformative gene-based therapies for human diseases.
What made this meeting different:
- A substantial proportion of the oral programme was given to talks selected from submitted abstracts to discuss innovative ideas
- There was a focus on closing the gap between new developments in CRISPR technology and application in life sciences
- There were networking opportunities at the attendee dinner at a famous venue in Dublin
2017 Abstracts
-
Take a look at the abstracts form last year’s event.
2017 Sponsors
- The Pathologist
- GEN
- The CRISPR Journal
Join the conversation by following @thecrisprforum on Twitter!